Skip to main
MDAI

MDAI Stock Forecast & Price Target

MDAI Analyst Ratings

Based on 1 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Spectral AI is a promising company with a strong focus on utilizing advanced AI algorithms to improve diagnostic capabilities for superficial wounds and burns. With its recent BARDA contract and ongoing development efforts for its DeepView System, the company is well-positioned for growth in the medical technology industry. Additionally, Spectral AI's license model and high margins make it an attractive investment for potential investors.

Bears say

Spectral AI is expected to have lower revenue due to longer clinical and regulatory timelines, setbacks in approvals, and lower uptake of its DeepView System. The company also faces risks such as limited awareness of the technology and delays in regulatory and clinical timelines. Additionally, while the Advanced Wound Care market is large, under-penetrated, and disjointed, MDAI may face competition in its target markets. With limited operating history, it may take some time for the company to establish itself and generate significant revenue.

MDAI has been analyzed by 1 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Spectral AI Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Spectral AI Inc (MDAI) Forecast

Analysts have given MDAI a Strong Buy based on their latest research and market trends.

According to 1 analysts, MDAI has a Strong Buy consensus rating as of May 6, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $3, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $3, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Spectral AI Inc (MDAI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.